Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: gasp (9), gulp (3)

Volunteers needed to optimise steroid doses in patients with asthma

Description: Auto Generated Title We are looking for volunteers aged 18 to 80, with a diagnosis of asthma to take part in
Url: /ClinicalResearchinSouthampton/Public-and-patients/Featured-research-studies/Featuredresearchoptimise-steroid-doses-in-patients-with-asthma.aspx

Hydroxycarbamide

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia (CML) Hydroxycarbamide Regimen • CML - Hydroxycarbamide Indication • Chronic or accelerated phase chronic myeloid leukaemia in those who
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Hydroxycarbamide.pdf

The Respiratory Centre – nebuliser loan service - patient information

Description: This factsheet explains how to care for and maintain your nebuliser.
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/The-Respiratory-Centre-–-nebuliser-loan-service-1110-PIL.pdf

Stopping smoking before your cardiac operation - patient information

Description: This factsheet contains some helpful tips on how to stop smoking before your cardiac operation.
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Stopping-smoking-before-your-cardiac-operation-3988-PIL.pdf

DVdSC (weekly cycles 9 onwards) DaratumumabSC-Bortezomib-Dexamethasone Ver1

Description: Chemotherapy Protocol Myeloma DVd SC (weekly) Bortezomib Daratumumab Dexamethasone Cycles 9 onwards Regimen • Myeloma – Bortezomib with daratumumab and dexamethasone Indication • Daratumumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdSC-weekly-cycles-9-onwards-DaratumumabSC-Bortezomib-Dexamethasone-Ver1.pdf

Daratumumab SC Ver1

Description: Chemotherapy Protocol Myeloma Daratumumab Subcutaneous Regimen • Myeloma – Daratumumab (SC) Indication • Daratumumab monotherapy is recommended as an option for treating relapsed and
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Daratumumab-SC-Ver1.pdf

DRD Daratumumab-Lenalidomide-Dexamethasone

Description: Chemotherapy Protocol Myeloma DRD Daratumumab-Lenalidomide-Dexamethasone Regimen • Myeloma – DRD Daratumumab-Lenalidomide-Dexamethasone Indication • Daratumumab in combination with lenalidomide and dexamethasone
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DRD-Daratumumab-Lenalidomide-Dexamethasone.pdf

DVd-T SC Bortezomib-Daratumumab-Dexamethasone-Thalidomide v1

Description: Details of the Chemotherapy Protocol for Myeloma.
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-T-SC-Bortezomib-Daratumumab-Dexamethasone-Thalidomide.pdf

DVdSC (weekly cycles1-8) Bortezomib-Daratumumab-Dexamethasone Ver1

Description: Chemotherapy Protocol Myeloma DVd SC (weekly cycles 1-8) Bortezomib-Daratumumab-Dexamethasone Regimen • Myeloma – DVd SC (weekly cycles 1-8) bortezomib
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdSC-weekly-cycles1-8-Bortezomib-Daratumumab-Dexamethasone-Ver1.pdf

Prof John Fleming, scientific lead for imaging group

Description: NIHR Southampton Biomedical Research Centre Auto Generated Title Prof Fleming is a clinical scientist working on the use of medical imaging
Url: /ClinicalResearchinSouthampton/Our-people/Respiratory-research-people/Prof-John-Fleming,-scientific-lead-for-imaging-group.aspx

1 to 10 of 31

Previous 1 2 3 4 Next